Topic:

Partnering

Latest Headlines

Latest Headlines

Vertex beefs up its cystic fibrosis pipeline with $1.2B Parion R&D pact

With its cystic fibrosis combo drug awaiting a likely approval at the FDA, Vertex is beefing up its pipeline in the field, paying $80 million upfront and promising up to $1.1 billion more in milestones to partner with Parion Sciences on a new class of CF-related drugs.

Exact Sciences joins forces with MD Anderson for lung cancer Dx development

Exact Sciences is teaming up with the MD Anderson Cancer Center to develop a blood-based diagnostics for lung cancer, looking to expand its offerings past its innovative colorectal cancer screening test and gain some ground in a rapidly growing market.

LabCorp inks a cancer deal with Covance in mind

LabCorp, now the owner of CRO giant Covance, partnered up with Japan's Sysmex to bring in some new technology it believes will make its subsidiary more competitive in the market for oncology clinical trials.

WuXi lands a role in the U.K.'s plot to sequence 100,000 genomes

WuXi PharmaTech's NextCODE secured a spot among the companies and research institutions taking part in Genomics England, contending for a lead role in the group's ambitious effort to sequence the genomes of 100,000 people.

Dexcom, Insulet partner with diabetes data startup Glooko as it expands into insulin pumps, CGMs

Glooko's mission is to integrate data from existing diabetes devices into an app for patients and a population management platform for payers and healthcare providers. It's diving into continuous glucose monitors and insulin pumps with a pair of deals--one for the Dexcom CGM and the other for the Insulet OmniPod pump.

Recipharm signs on to develop Follicum's hair-growth drug

Contract drug developer Recipharm has inked a deal with Swedish biotech Follicum to help get the company's top prospect into clinical trials, handling formulation and production.

Celgene narrows pioneering CAR-T collaboration with bluebird bio, hands over $25M sweetener

Two years after Celgene dangled a selection of $225 million milestone prizes in front of bluebird bio in exchange for collaborating on a range of CAR-T cancer drug programs, the Big Biotech has narrowed its sights to a single target and chipped in a $25 million payment to move their lead candidate into the clinic soon.

AMRI partners up in drug discovery amid a corporate turnaround

Contract drugmaker AMRI is shifting some of its focus to early-stage R&D, partnering up with a neighboring biotech to expand its capabilities in drug discovery.

Former Stryker R&D exec spins off new company with novel bone adhesive

New startup LaunchPad Medical has in-licensed a bone adhesive candidate from Stryker. The company is headed by a former R&D manager at Stryker, Brian Hess, who the company named Co-Innovator of the Year in 2010 for his work on this bone adhesive, Tetranite.

SK Biopharmaceuticals says Jazz-led sleep disorder PhIII candidate on the cards

South Korea's SK Biopharmaceuticals announced Phase III clinical trials of a medication for sleep disorders that will be led abroad by partner U.S.-based Jazz Pharmaceuticals, the Korea Herald said.